Experts led by chairman Sang inspected BIOasis’s technological platform such as Biotechnology Center, Long-Acting and Targeting Drug Technology Center and Pilot Plant and carefully listened to the technical director about the platform, the core technology and major new drug project's progress.

In the ensuing discussion, Liu Dianbo and Fu Fenghua, general manager of BIOasis, respectively made reports about BIOasis to the experts. Chairman Sang affirmed the operating model of the park and spoke highly of humanized antibody transgenic mouse technology, long-term sustained release microsphere preparations and other major international research projects. At last, Chairman Sang encouraged BIOasis to do actively exploration and develop deep cooperation with effectiveness.